ASH 2016: Subtyping in Diffuse Large B-Cell Lymphoma

NanoString at ASH 2016. We attended the annual meeting of the American Society of Hematology (ASH) in San Diego. The convention center was abuzz with scientists sharing their research on the clinical utility of stem cells, the mechanics of the...

/ January 4, 2017

The Cancer Immunogram: A Picture of Personalized Medicine

What do we already know about tumor-immune system interactions, and how can this information be used to help guide us toward the best therapeutic choice? That is exactly the question that a group of researchers from the Netherlands Cancer Institute,...

/ December 27, 2016

SITC 2016 Recap

Looking beyond anti-PD1/PDL1 with combination therapy and gene signature testing

/ November 21, 2016

The IO Revolution, Part 1 of 4: Opportunities and Challenges

Immuno-oncology (IO) focuses on harnessing the tremendous power of the human immune system to detect and destroy cancer cells.

/ November 21, 2016